Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03675308
Brief Title: A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy (KEEPsAKE 1)

First Submitted : September 12, 2018
First Submitted that Met QC Criteria : September 15, 2018
First Posted : September 18, 2018

Results First Submitted : January 24, 2022
Results First Posted with QC Comments : February 16, 2022
Results First Submitted that Met QC Criteria : February 23, 2022
Results First Posted : February 24, 2022

Certification/Extension First Submitted : September 21, 2021
Certification/Extension First Submitted that Met QC Criteria : February 23, 2022
Certification/Extension First Posted : February 24, 2022

Last Update Submitted that Met QC Criteria : February 23, 2022
Last Update Posted : February 24, 2022